SignalChem enters a clinical trial collaboration with Merck to evaluate the effect of SLC-391 in combination with KEYTRUDA® (pembrolizumab) in advanced non-small cell lung cancer
March 25, 2021
March 25, 2021
March 8, 2021
December 21, 2020
December 10, 2020
October 22, 2020
October 14, 2020
July 7, 2020
June 25, 2020
June 11, 2020
June 16, 2026
New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen...
June 16, 2026
Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience...
June 8, 2026
Alithea Genomics, a pioneering biotech company specializing in scalable RNA sequencing solutions, today announced a new agreement with Revvity Inc. to...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225